ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      58,014.26
      2.41%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      04/07/20228:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/04/20228:00AMGlobeNewswire Inc.Lexicon Welcomes New Guidelines for the Management of Heart FailureNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/02/202212:15PMGlobeNewswire Inc.Sotagliflozin Improved Outcomes in Patients With and Without Prior Cardiovascular Disease in New Analysis Presented at the American College of Cardiology's 71st Annual Scientific Session (ACC.22)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/21/20228:01AMGlobeNewswire Inc.New Analysis of Cardiovascular Endpoints in the SCORED Trial to Be Presented at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/17/20224:14PMGlobeNewswire Inc.Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Commercialization of SotagliflozinNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/11/20225:16PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/10/20225:24PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20227:13AMDow Jones NewsLexicon Pharma Shares Fall Premarket on Withdrawn FDA ApplicationNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20226:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20226:01AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Clinical UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20226:00AMGlobeNewswire Inc.Lexicon Voluntarily Withdraws Sotagliflozin New Drug Application and Plans Prompt Resubmission Targeted Early Q2 2022NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/25/20229:03PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Fourth Quarter 2021 Financial Results Conference Call and Webcast on February 28, 2022NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20226:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20226:10AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/11/20225:41PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/09/20229:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/13/20229:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Outlines Major Potential Value Drivers for 2022 at 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/10/20224:18PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/04/20226:43PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/04/20224:05PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in The 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/30/20214:05PMGlobeNewswire Inc.Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/15/20214:30PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference and the Piper Sandler 33rd Annual Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX